alexa
Reach Us +1-947-333-4405
Aims and Scope - Journal of Clinical Trials
ISSN: 2167-0870

Journal of Clinical Trials
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aims and Scope

 » Journal of Clinical Trials (JCTR) is a broad-based journal founded on two key tenets: To publish the most exciting researches on the role of Clinical Trials in Medical and pharmaceutical sciences. Secondly, to provide a rapid turn-around time possible for reviewing and publishing and to disseminate the articles freely for research, teaching and reference purposes. It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers and professional bodies and institutions.
 » All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. JCTR strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. JCTR will keep up-to- date with latest advances in the field of Clinical Trials. Abstracts and full texts (HTML, PDF and XML format) of all articles published by JCTR are freely accessible to everyone immediately after publication. JCTR supports the Bethesda Statement on Open Access Publishing.
Top